GB202016359D0
|
|
Gas sensing apparatus
|
WO2021060980A1
|
|
Antibiotic compounds
|
GB202009341D0
|
|
Apparatus
|
WO2020236001A1
|
|
Analyzing brain functioning using behavioral event markers from portable electronic device
|
GB202004372D0
|
|
Junction, device and methods of fabrication
|
WO2020060401A2
|
|
Bioactive peptides derived from snakes
|
WO2020046132A1
|
|
Pharmacological chaperones for enzyme treatment therapy
|
NL2023196B1
|
|
Analyzing brain functioning using behavioral event markers from portable electronic device
|
NL2022854B1
|
|
Prodrug inhibitors
|
WO2019160419A1
|
|
Tripodal squaramide-based monomers
|
NL2022019B1
|
|
Method for Matrix Effect Correction in Quantitative Mass Spectrometric Analysis of Analytes in Complex Matrices.
|
NL2021840B1
|
|
Pharmacological Chaperones For Enzyme Treatment Therapy
|
EP3575287A1
|
|
Inhibitors of n-acylphosphatidylethanolamine phospholipase d (nape-pld)
|
NL2020863B1
|
|
Apparatus for determining presence of a gas
|
EP3615062A1
|
|
Adjuvant compounds
|
NL2020453B1
|
|
Tripodal squaramide-based monomers
|
EP3502259A1
|
|
A combinational strategy for reducing random integration events when transfecting plants
|
WO2019096416A1
|
|
Hybrid superconducting-ferromagnet random access memory element
|
NL2019801B1
|
|
Delivery vectors
|
NL2019752B1
|
|
Cytotoxic Complexes
|